VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 31, 2007) - Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced that its biotech method for 7ACA production has been successfully implemented on a new production line. Management believes this achievement validates the Company’s research and development efforts to improve its manufacturing technology. This technology would bring immediate benefits to production operations by increasing production efficiency and by eliminating the use of chemicals thus reducing our disposal costs and protecting the environment. Further, we believe that the overall adoption of the technology in our operations will reduce production costs which would enhance the Company’s competitiveness in global market.
